Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
22 hedge funds and large institutions have $699K invested in Nemaura Medical, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.
47% more funds holding
Funds holding: 15 → 22 (+7)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
73% less capital invested
Capital invested by funds: $2.61M → $699K (-$1.91M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14K |
| 2 |
VF
Virtu Financial
New York
|
+$8.46K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.2K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$1.95K |
| 5 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
+$346 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$444K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.9K |
| 3 |
BlackRock
New York
|
-$763 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$114 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$59 |
NMRD Hedge Fund Activity: Q3 2023 in Review
22 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q3 2023, worth a combined $699K — down 73% from $2.61M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NMRD positions and 0 closed out — a net gain of 7 holders — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $14K. The largest seller was Alyeska Investment Group, cutting an estimated $444K.
- 22 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q3 2023, up from 15 in Q2 2023.
- Funds reported $699K of Nemaura Medical, Inc. Common Stock stock for Q3 2023, down 73% quarter-over-quarter.
- 7 funds opened new Nemaura Medical, Inc. Common Stock positions in Q3 2023 and 0 closed out, a net change of +7 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q3 2023 was Susquehanna International Group, an estimated $14K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q3 2023 was Alyeska Investment Group, an estimated $444K sold.
Based on aggregated 13F filings for Q3 2023.